First Patient-led Crowdfunding Initiative for Multiple Myeloma Research Tops $500,000 to Fund Two Projects
The first patient-led crowdsourcing and crowdfunding initiative for…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe first patient-led crowdsourcing and crowdfunding initiative for…
Janssen Pharmaceuticals has requested the U.S. Food and…
The first-ever Multiple Myeloma Research Foundation (MMRF)…
Antibody-drug conjugates (ADCs), a class of drugs in which…
BioLineRx’s investigational drug BL-8040 has demonstrated positive interim results from…
By activating the immune system, the experimental drug LCL161…